Cargando…

Medication Use Patterns and Predictors of Nonpersistence and Nonadherence with Oral 5-Aminosalicylic Acid Therapy

BACKGROUND: 5-aminosalicylic acid (5-ASA) is the recommended first-line treatment for active mild-to-moderate ulcerative colitis (UC) and for maintenance of UC remission. However, persistence and adherence to prescribed 5-ASAs are often suboptimal. OBJECTIVES: To evaluate 5-ASA medication use patter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Linnette, Wu, Joanne, Hodgkins, Paul, Cohen, Russell D., Nichol, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437351/ https://www.ncbi.nlm.nih.gov/pubmed/23206213 http://dx.doi.org/10.18553/jmcp.2012.18.9.701

Ejemplares similares

A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation
por: Wirbka, Lucas, et al.
Publicado: (2022)

Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder
por: Ta, Jamie T, et al.
Publicado: (2021)

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
por: Mitra, Debanjali, et al.
Publicado: (2012)

Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review
por: Okada, Mali, et al.
Publicado: (2021)

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
por: Lachaine, Jean, et al.
Publicado: (2013)

The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX(®) formulated delayed-release mesalamine
por: Yarlas, Aaron, et al.
Publicado: (2014)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
por: Lee, Jin, et al.
Publicado: (2019)

Predictors of uncontrolled hypertension and antihypertensive medication nonadherence
por: Morgado, Manuel, et al.
Publicado: (2010)

Para-Aminosalicylic Acid: Pas
Publicado: (1950)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
por: Uchiyama, Kazuhiko, et al.
Publicado: (2023)

Prenatal Exposure to Nonpersistent Endocrine Disruptors and Behavior in Boys at 3 and 5 Years
por: Philippat, Claire, et al.
Publicado: (2017)

Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology
por: Calafat, Antonia M., et al.
Publicado: (2015)

Nonpersistent endocrine disrupting chemicals and reproductive health of women
por: Cho, Yeon Jean, et al.
Publicado: (2020)

Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants
por: Maclean, J Ross, et al.
Publicado: (2011)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

p-Aminosalicylic Acid (P.A.S.)
por: Spring, F. S.
Publicado: (1949)

Erratum: “Prenatal Exposure to Nonpersistent Endocrine Disruptors and Behavior in Boys at 3 and 5 Years”
por: Philippat, Claire, et al.
Publicado: (2018)

Comment on “Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology”
por: Stahlhut, Richard W., et al.
Publicado: (2016)

Common but Nonpersistent Acquisitions of Plant Viruses by Plant-Associated Fungi
por: Cao, Xinran, et al.
Publicado: (2022)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid
por: Shrivastava, P. K., et al.
Publicado: (2013)

The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
por: Rousseaux, Christel, et al.
Publicado: (2013)

Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps
por: Kirchner, Tina, et al.
Publicado: (2013)

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
por: Broekman, Mark M. T. J., et al.
Publicado: (2015)

The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats
por: Banaei, Shokofeh
Publicado: (2016)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

Prevalence and predictors of primary nonadherence to medications prescribed in primary care
por: Zeitouny, Seraphine, et al.
Publicado: (2023)

Medication nonadherence and psychiatry
por: Chapman, Sarah C.E., et al.
Publicado: (2013)

Response to “Comment on ‘Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology’”
por: Calafat, Antonia M., et al.
Publicado: (2016)

Controlled Release of 5-Aminosalicylic Acid (5-ASA) from New Biodegradable Polyurethanes
por: Kenawy, El-Refaie, et al.
Publicado: (2010)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
por: van der Horst, Sabine F. B., et al.
Publicado: (2023)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
por: Sener, Aziz, et al.
Publicado: (2018)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019)

Psychosocial predictors of nonadherence to medical management among patients on maintenance dialysis
por: Alosaimi, Fahad Dakheel, et al.
Publicado: (2016)

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase
por: Madarame, Akira, et al.
Publicado: (2021)

Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
por: Fossmark, Reidar, et al.
Publicado: (2021)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
por: Perrotta, Cristiana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ppnaie6c9u1rkk9np4q2da2agc